RNTX Stock Analysis: Buy, Sell, or Hold?
RNTX - Rein Therapeutics, Inc. Common Stock
$1.30
-0.13 (-9.09%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When RNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RNTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RNTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RNTX is currently trading at $1.30, which is considered fair relative to its 30-day fair value range of $1.13 to $1.39.
Technical Outlook: Technically, RNTX is showing sideways momentum. Immediate support is located at $1.12, while resistance sits at $1.63. Short-term momentum is weak, with the stock down 9.1% recently.
Market Sentiment: RNTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+669.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RNTX is showing sideways momentum. Immediate support is located at $1.12, while resistance sits at $1.63. Short-term momentum is weak, with the stock down 9.1% recently.
Market Sentiment: RNTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+669.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.13 -
$1.39
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
Protect Your Profits
Holding RNTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.1%)
- BULLISH: Trading 669.2% below Wall St target ($10.00)
- CAUTION: Recommendation downgraded due to -5.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.13 -
$1.39
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.12
Resistance Level
$1.63
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-1.62
Wall Street Target
$10.00
(+669.2%)
Last updated: February 01, 2026 8:07 AM ET
Data refreshes hourly during market hours. Next update: 9:07 AM
Data refreshes hourly during market hours. Next update: 9:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNTX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
Advanced RNTX Option Strategies
Professional options setups generated by AI based on today's RNTX price and gamma walls.